Doctors can often diagnose liver cancer with a CT scan and blood tests. A biopsy may be needed if imaging results are inconclusive. Liver cancer is often diagnosed after someone develops symptoms such ...

A new blood test may help detect liver cancer earlier in people with chronic liver disease, potentially improving access to ...

Non-alcoholic fatty liver disease (NAFLD) is among the most prevalent chronic liver disorders worldwide and can sometimes lead to severe conditions like cirrhosis and hepatocellular carcinoma. As such ...

A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...

According to the Centers for Disease Control and Prevention (CDC), approximately 25,000 men and 11,000 women are diagnosed with liver cancer each year. Early detection and treatment are key to ...

Non-alcoholic fatty liver disease (NAFLD) is the term for a range of conditions caused by a build‑up of fat in the liver. NAFLD develops in 4 stages: simple fatty liver (steatosis): a largely harmless ...

Ultrasound scanning, along with other imaging technologies such as CT and MRI, is important in diagnosing and planning treatment for many people with liver disease. Liver imaging sometimes identifies ...

A recent study at the Medical University of South Carolina's (MUSC) Digestive Disease Research Core Center (DDRCC) provides insight into why physicians should be cautious when using a certain liver ...

Given just how much lifestyle disorders or non-communicable diseases are on the rise these days, it is quite likely that you would have taken a liver function test (LFT) and then consulted the doctor ...

A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...